semaglutide compound diarrhea Diarrhea: How Long Does It Last and Management Tips Compounded Semaglutide Diarrhea: Managing GLP-1

Lilly is studying retatrutide in several Phase 3 clinical trials to evaluate its potential efficacy and safety in obesity and overweight with at least one weight-related medical problem, type 2 diabetes, knee osteoarthritis, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes and metabolic dysfunction-associated steatotic liver disease

A 2025 study published ahead of the Endocrine Society annual meeting found that consuming more protein was directly protective against muscle loss in people taking anti-obesity medications

However, when semaglutide is part of the picture, these ratios need some adjustment

In the trial, 930 adults with type 2 diabetes were randomly assigned to receive weekly retatrutide or placebo

10.2337/db14-1577 176